IFNA1 and systemic lupus erythematosus: Patients with SLE and with an MDA5 gain-of-function mutation R779H (rs587777446) have increased IFN-α serum levels (75), which may be due to dysregulated helicase ATP hydrolysis and dsRNA binding (76).